Analysts have raised their price target for Hanover Insurance Group from $197.00 to $199.43, citing expectations for stronger revenue growth and a modestly higher projected valuation, even though profit margins are expected to soften slightly.
What's in the News
- From July 1, 2025 to October 27, 2025, Hanover Insurance Group repurchased 323,000 shares, representing 0.9 percent of shares outstanding, for $55 million (Key Developments).
- The company has now completed the repurchase of 8,622,511 shares, totaling 22.22 percent of shares outstanding, for $1,093.29 million under its buyback program announced in 2018 (Key Developments).
- The Hanover Insurance Group expanded its Business Owner's Advantage product to serve a broader range of life sciences organizations with over 15 new eligible classes, including medical device manufacturers and digital health companies (Key Developments).
- Key product enhancements include tailored property and liability coverage, a streamlined digital quoting and issuance platform, and expanded support for early-stage, smaller life sciences firms (Key Developments).
Valuation Changes
- The Fair Value Estimate has increased slightly, rising from $197 to $199.43.
- The Discount Rate remains unchanged at 6.78 percent.
- The Revenue Growth projection has been raised moderately from 4.29 percent to 4.55 percent.
- The Net Profit Margin is expected to soften, falling from 8.77 percent to 8.45 percent.
- The Future P/E Ratio estimate has inched higher, moving from 12.79x to 13.13x.
Have other thoughts on Hanover Insurance Group?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.